Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 538.00
Bid: 540.00
Ask: 543.00
Change: 0.00 (0.00%)
Spread: 3.00 (0.556%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 538.00
POLR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AUM Update

10 Apr 2015 07:00

RNS Number : 7922J
Polar Capital Holdings PLC
10 April 2015
 

10 April 2015

Polar Capital Holdings plc

AUM Update

 

 

Polar Capital Holdings plc ("Polar Capital" or the "Group") the specialist asset manager today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AUM").

 

 

Group AUM (unaudited)

Polar Capital reports that as at 31 March 2015 its AUM were $12.3bn compared to $12.9bn at the end of December 2014 and $13.2bn at the end of March 2014.

 

The table below sets out the movements in Polar Capital's AUM over the twelve month period:

AUM movement

twelve months to 31 March 2015

Long only funds

$m

Alternative funds

$m

Total

$m

As at 31 March 2014

$12,315m

$934m

$13,249m

Net subscriptions / (redemptions)

$(2,228)m

$254m

$(1,974)m

Closure of EMN team

Nil

$(67)m

$(67)m

Market movement and performance

$1,098m

$(50)m

$1,048m

Total AUM at 31 March 2015

$11,185m

$1,071m

$12,256m

 

Comment

Net inflows across the Group's non Japan range of funds of $0.3bn over the past twelve months have been offset by $2.3bn of outflows from our Japan business ($1.6bn over the past six months) following both disappointing performance that has been exacerbated by the team's style bias, as well as uncertainty over the direction of the Japanese equity market. These Japan flows follow the $3.0bn of net inflows that were received in the previous twelve month period.

 

The combination of these Japan outflows with good inflows into a number of our other products over the year has delivered the side effect of making the business more balanced with Japan now accounting for some 30% of the Group's AUM down from its peak of 43%.

 

We continue to believe that over the medium term the Group is well placed to grow assets further given the number of products that have considerable scope for asset growth including the launch of 3 new funds over the past year. This assumes there is no meaningful deterioration in the overall outlook for global equity markets.

 

The confidence in our ability to grow assets in the medium term is a function of the strong performance of our products that can be demonstrated by the good performance numbers of Polar Capital's product range where 11 of our 14 Lipper rated open ended funds (with at least a 1 year track record) are over one year first or second quartile continuing the excellent record since inception.

 

 

1 year

3 Years

5 years

Since

inception

1st quartile

6 funds

5 funds

5 funds

10 funds

2nd quartile

5 funds

3 funds

N/A

3 funds

3rd quartile

1 fund

1 fund

1 fund

1 fund

4th quartile

2 funds

1 fund

N/A

N/A

 

 

For further information please contact:

 

Polar Capital

Tim Woolley (CEO)

John Mansell (COO)

+44 (0)20 7227 2700

Canaccord Genuity - Nomad and Broker

Simon Bridges (QE)

Martin Green

Sunil Duggal

Kit Stephenson

+44 (0)20 7523 8000

 

Camarco

Ed Gascoigne-Pees

 

+44 (0)20 3757 4984

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEASLNESPSEFF
Date   Source Headline
26th Nov 20187:00 amRNSUnaudited Interim Results
22nd Nov 20185:00 pmRNSDirectorate Change
5th Nov 20187:01 amRNSNotice of Results
5th Nov 20187:00 amRNSChange of Nominated Adviser and Broker
1st Nov 20187:00 amRNSTotal Voting Rights
25th Oct 20185:26 pmRNSIssue of Equity
24th Oct 20184:52 pmRNSDirector/PDMR Shareholding
17th Oct 20185:49 pmRNSIssue of Equity
15th Oct 201812:38 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
12th Oct 20182:52 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
11th Oct 20184:42 pmRNSIssue of Equity
11th Oct 20187:01 amRNSCrystallisation of business unit & issue of shares
11th Oct 20187:00 amRNSAUM Update
3rd Oct 201810:24 amRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
19th Sep 201811:52 amRNSForm 8.3 - Jardine Lloyd Thompson Group
18th Sep 201812:02 pmRNSForm 8.3 - Realm Therapeutics PLC
17th Aug 20189:27 amRNSDirectorate Change
6th Aug 20187:00 amRNSBlock listing Interim Review
1st Aug 20187:00 amRNSTotal Voting Rights
31st Jul 20185:57 pmRNSIssue of Equity
31st Jul 201811:29 amRNSDirector/PDMR Shareholding
25th Jul 20183:38 pmRNSDirectorate Change
25th Jul 20183:26 pmRNSResult of AGM
19th Jul 201811:13 amRNSForm 8.3 - Consort Medical Plc
18th Jul 20184:21 pmRNSDirector/PDMR Shareholding
18th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
17th Jul 201810:58 amRNSForm 8.3 - Consort Medical Plc
16th Jul 20183:44 pmRNSDirector/PDMR Shareholding
12th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
12th Jul 20187:00 amRNSAuM Update
11th Jul 201811:06 amRNSForm 8.3 - Consort Medical Plc
3rd Jul 20186:27 pmRNSHolding(s) in Company
3rd Jul 20186:20 pmRNSIssue of Equity
3rd Jul 201812:07 pmRNSForm 8.3 - Consort Medical Plc
2nd Jul 201810:23 amRNSTotal Voting Rights
29th Jun 20187:00 amRNSBlock Listing Application
28th Jun 20185:55 pmRNSAnnual Financial Report
25th Jun 20187:00 amRNSGroup Audited Results for year ended 31 March 2018
11th Jun 201811:27 amRNSNet Asset Value(s)
1st Jun 20187:41 amRNSTotal Voting Rights
24th May 201810:59 amRNSDirector/PDMR Shareholding
24th May 20189:35 amRNSIssue of Equity
23rd May 201811:00 amRNSNotice of Results
23rd May 20189:37 amRNSIssue of Equity
18th May 20181:02 pmRNSIssue of Equity
16th May 20185:49 pmRNSIssue of Equity
11th May 20187:00 amRNSIssue of Equity
10th May 20189:56 amRNSDirector/PDMR Shareholding
1st May 20183:52 pmRNSIssue of Equity
12th Apr 20187:00 amRNSAuM Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.